The PreOncology Program™
Cancer risk management built on whole genome sequencing, precision risk assessment, and continuous clinical guidance.
How the Program Works
The PreOncology Program uses whole genome sequencing, advanced cancer risk modeling, family history, lifestyle factors, and clinical data to personalize cancer risk management and early detection.
Primary care physicians introduce the program to clinically appropriate patients. Interested patients are referred to PreOncology and begin with the Stage Alpha Assessment, where medical oncologists build an individualized cancer risk profile and deliver a guideline-based surveillance protocol to the physician for review.
Risk is reassessed on an ongoing basis, with genomic reinterpretation as the science advances. Elevated or changing risk, surveillance needs, or physician guidance may lead PreOncology to take a more active role, coordinating directly with the physician to order and manage a member’s ongoing surveillance testing.
The Stage Alpha Assessment
Step 1
Blood Draw
A single blood draw that produces a oncology specific genomic analysis that is more comprehensive than any hereditary cancer risk genetic testing currently available. This test is performed once and continuously reinterpreted as science advances.
Step 2
Precision Risk Assessment
A structured clinical intake capturing personal and family history, lifestyle factors, and other clinically relevant inputs used to build each member’s risk profile.
Step 3
Initial Consultation with the Prevention Care Team
A dedicated review session in which the Prevention Care Team presents the member’s personalized risk profile. The team includes a nurse practitioner specializing in risk management and early detection, and an oncology-specialized genetic counselor.
Following the Initial Consultation, a full report is presented to the member and their primary care physician.
Screening Technologies
